DECIPHERA PHARMACEUT

DCPH
Real-time Estimate Quote. Real-time Estimate  - 01/19 12:14:46 pm
8.705USD +5.26%

Barclays Downgrades Deciphera Pharmaceuticals to Equal-Weight Rating From Overweight, Adjusts Price Target to $11 From $50

11/08/2021 | 08:29am
MarketScreener.com
This article is reserved for subscribers
A "one-stop shopping" service for investors
The best opportunities, portfolios, and screeners
Discover